Search
Patexia Research
Case number 1:21-cv-01764

InfoRLife SA et al v. Hikma Pharmaceuticals USA Inc. > Documents

Date Field Doc. No.Description (Pages)
Jun 7, 2022 25 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joseph B. Sherling and Charles K. Shih of Neal, Gerber & Eisenberg LLP - filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick)
Jun 7, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [25] MOTION for Pro Hac Vice Appearance of Attorney Joseph B. Sherling and Charles K. Shih of Neal, Gerber & Eisenberg LLP, filed by Hikma Pharmaceuticals USA Inc. Ordered by Judge Colm F. Connolly on 6/7/2022. (kmd)
Mar 29, 2022 24 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (i) Hikma Pharmaceutical USA Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and, (ii) Defendant Hikma Pharmaceutical USA Inc.'s Disclosures Pursuant to Delaware Default Standard Paragraph 3 filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick)
Mar 4, 2022 23 Order (2)
Docket Text: ORDER that Civil Action No. 21-1740-CFC and Civil Action No. 21-1764-CFC are consolidated for all purposes. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-1740-CFC ONLY. Order Setting Telephonic Scheduling Conference:( A Scheduling Conference is set for 3/22/2022 at 11:30 AM Telephonically before Judge Colm F. Connolly.) If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 3/4/2022. Associated Cases: 1:21-cv-01740-CFC, 1:21-cv-01764-CFC(nmf)
Mar 4, 2022 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:21-cv-01740-CFC. ALL FUTURE FILINGS SHOULD BE MADE IN LEAD CASE NO. 21-1740-CFC ONLY. (nmf)
Mar 3, 2022 22 Letter (1)
Docket Text: Letter to The Honorable Colm F. Connolly from Dominick T. Gattuso, Esq. regarding Consolidation and Scheduling Conference - re (21 in 1:21-cv-01764-CFC) Letter. (Gattuso, Dominick)
Mar 2, 2022 21 Letter (2)
Docket Text: Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding consolidation - re (11 in 1:21-cv-01764-CFC, 11 in 1:21-cv-01764-CFC, 22 in 1:21-cv-01740-CFC, 22 in 1:21-cv-01740-CFC) Order,, Set Deadlines,. (Blumenfeld, Jack)
Feb 23, 2022 20 Main Document (28)
Docket Text: REDACTED VERSION of [18] Answer to Amended Complaint, Counterclaim by Hikma Pharmaceuticals USA Inc.. (Attachments: # (1) Exhibit 1-5, # (2) Certificate of Service)(Gattuso, Dominick)
Feb 23, 2022 20 Exhibit 1-5 (53)
Feb 23, 2022 20 Certificate of Service (1)
Feb 18, 2022 19 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceuticals, PLC for Hikma Pharmaceuticals USA Inc. filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick)
Feb 17, 2022 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: D.I. [16] has been replaced to reflect the correct date. (kmd)
Feb 17, 2022 16 Stipulation (2)
Docket Text: STIPULATION for Hikma to File its Answer to the First Amended Complaint under seal re [13] Amended Complaint by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Main Document 16 replaced on 2/17/2022) (kmd).
Feb 17, 2022 17 SO ORDERED (2)
Docket Text: SO ORDERED, re [16] Stipulation for Hikma to File its Answer to the First Amended Complaint under seal, filed by Hikma Pharmaceuticals USA Inc. Signed by Judge Colm F. Connolly on 2/17/2022. (kmd)
Feb 7, 2022 15 Amended Complaint* (1)
Feb 7, 2022 14 Order on Motion to Seal (1)
Docket Text: ORDER granting [12] Motion to Seal. Signed by Judge Colm F. Connolly on 2/7/2022. (kmd)
Feb 7, 2022 15 Redacted Document (25)
Docket Text: REDACTED VERSION of [13] Amended Complaint by InfoRLife SA, WG Critical Care, LLC. (Dellinger, Megan)
Feb 4, 2022 11 Order (2)
Docket Text: ORDER: IT IS ORDERED that, on or before March 4, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 3/4/2022.) Signed by Judge Colm F. Connolly on 2/4/2022. Associated Cases: 1:21-cv-01740-CFC, 1:21-cv-01764-CFC(nmf)
Feb 4, 2022 12 Motion to Seal (6)
Docket Text: MOTION to Seal (Unopposed) - filed by InfoRLife SA, WG Critical Care, LLC. (Dellinger, Megan)
Jan 11, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Jeffrey S. Ward for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Jan 11, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Emer Simic for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Jan 10, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Jeffrey S. Ward and Emer Simic of Neal, Gerber & Eisenberg LLP, filed by Hikma Pharmaceuticals USA Inc. Ordered by Judge Colm F. Connolly on 1/10/2022. (kmd)
Jan 10, 2022 10 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey S. Ward and Emer Simic of Neal, Gerber & Eisenberg LLP - filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick)
Jan 5, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Caitlin M. Wilmot, Jennifer P. Nock, and Steven Lieberman for InfoRLife SA and WG Critical Care, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Dec 22, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
Dec 22, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [8] STIPULATION TO EXTEND TIME Answer to Complaint to February 8, 2022, filed by Hikma Pharmaceuticals USA Inc. Reset Answer Deadlines: Hikma Pharmaceuticals USA Inc. answer due 2/8/2022. Ordered by Judge Colm F. Connolly on 12/22/2021. (kmd)
Dec 22, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Steven Lieberman, Jennifer Nock and Caitlin M. Wilmot, filed by InfoRLife SA, WG Critical Care, LLC. Ordered by Judge Colm F. Connolly on 12/22/2021. (kmd)
Dec 22, 2021 9 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven Lieberman, Jennifer Nock and Caitlin M. Wilmot - filed by InfoRLife SA, WG Critical Care, LLC. (Blumenfeld, Jack)
Dec 20, 2021 8 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME Answer to Complaint to February 8, 2022 - filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick)
Dec 17, 2021 7 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by InfoRLife SA, WG Critical Care, LLC. Hikma Pharmaceuticals USA Inc. served on 12/17/2021, answer due 1/7/2022. (Blumenfeld, Jack)
Dec 16, 2021 1 Main Document (11)
Docket Text: COMPLAINT filed against Hikma Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3765164.) - filed by InfoRLife SA, WG Critical Care, LLC. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(myr)
Dec 16, 2021 6 Summons Issued (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Hikma Pharmaceuticals USA Inc. on 12/16/2021. (myr)
Dec 16, 2021 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate ACS Dobfar, S.p.A. for InfoRLife SA; Corporate Parent Pharmasphere, Inc., Corporate Parent Harpgrove Limited for WG Critical Care, LLC filed by InfoRLife SA, WG Critical Care, LLC. (myr)
Dec 16, 2021 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,966,990 B2. (myr)
Dec 16, 2021 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 4,2021. Date of Expiration of Patent: June 20,2038.Thirty Month Stay Deadline: 5/4/2024. (myr)
Dec 16, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
Dec 16, 2021 1 Civil Cover Sheet (1)
Dec 16, 2021 1 Exhibit A (8)
Dec 16, 2021 1 Complaint* (1)
Menu